Skip to main content

Medication Leading Cause of Child Poisoning in US

March 21, 2012 — Roughly 165 young children in the U.S. are treated in the emergency departments every day after getting into medications, says a new report from Safe Kids Worldwide. That's more than 60,000 kids a year ages 5 and under who unintentionally take a medicine or overdose on it.
Over the last 25 years, the poisoning death rate among American children ages 14 and under has steadily dropped. But during this same time period, the number of poisoning deaths linked to accidental medication poisoning has almost doubled from 36% in 1979 to about 64% in 2006.
With more medications than ever available in homes, whether it's prescription drugs, over-the-counter medicines, vitamins, herbs, and dietary supplements, this increases the chances a young person might accidentally swallow one of these products.
It's not only that a child might see medicine bottles around the house more often. Our fast-paced lifestyles may also be at fault: Family members might forget to properly store medicine away from children's reach after taking it.
Or a parent or grandparent might forget a pill bottle is in a handbag or briefcase. Or a brother or sister might leave medicine in a backpack or drawer that small hands and curious minds can get into.
The Safe Kids report suggests that 95% of unintentional medication overdose visits to emergency departments are caused by a young child who got into a medicine while a parent or caregiver wasn't looking. Five percent are due to dosing errors made by caregivers.
Safe storage and safe dosing of medications are the keys to safe kids, according to the report.
Tips for Safe Medicine Storage
Which products are children accidentally swallowing most often?
Based on calls made to poison control centers in 2010, pain relievers — both prescription and over-the-counter — accounted for 31% of fatal poisonings in children age 5 and under. Allergy pills and sedatives, such as sleeping pills or antidepressants, each represent 17% of fatal poisonings in youngsters.
To help clinicians advise parents and caregivers on how to prevent medicine-related emergencies, here are six safety tips from the CDC's "Up and Away and Out of Sight" educational program:
  • Store medicine in a safe and secure location that's out of sight and reach of young children (even if another dose needs to be given in a few hours). Don't refer to medicines as candy.
  • Ask guests and babysitters to keep coats, purses, and bags with medicines in them up and away and out of sight when they visit your home.
  • Close child-resistant caps on medicine bottles every time and keep them off counters.
  • Don't use kitchen spoons to measure medicine since they are inaccurate.
  • Adults should avoid taking their medicine in front of children because they like to imitate grownups.
SOURCES:
Safe Kids Worldwide: "Safe Storage, Safe Dosing, Safe Kids: A Report to the Nation on Safe Medication."
Safe Kids Worldwide: "Medicine Safety Tip Sheets."

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volume delivered to

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n